StockWatch
·
Pharmaceuticals
Subsidiary18 Sept 2026, 06:01 pm

Indoco Remedies to Incorporate Wholly Owned Subsidiary

AI Summary

Indoco Remedies Ltd announced that its Committee of Executive Directors has approved the incorporation of a wholly owned subsidiary, 'Warren Lifesciences Private Limited'. The new entity will operate in the pharmaceutical sector, focusing on manufacturing, development, and sales of pharmaceutical products including APIs and finished formulations. The incorporation is subject to regulatory approvals. The subsidiary will have an authorized and paid-up capital of ₹1,00,000, with Indoco Remedies holding 100% shareholding. This move aims to expand the company's business operations in the pharmaceutical domain.

Key Highlights

  • Indoco Remedies approved incorporation of 'Warren Lifesciences Private Limited'.
  • The subsidiary will focus on pharmaceutical products and APIs.
  • Indoco Remedies will hold 100% shareholding in the new entity.
  • Initial capital is ₹1,00,000, shares at face value of ₹10.
  • Incorporation is subject to regulatory approvals.